{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:37:05Z","timestamp":1790102225675,"version":"4.0.1"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00584","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T08:49:03Z","timestamp":1566550143000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":81,"title":["Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging"],"prefix":"10.3389","volume":"10","author":[{"given":"Stefania","family":"Gorini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Kyum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Infante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mammi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"La Vignera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris Z.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Caprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10741-005-2344-2","article-title":"Mineralocorticoid receptors: distribution and activation","volume":"10","author":"Funder","year":"2005","journal-title":"Heart Fail Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.1123348","article-title":"Evolution of hormone-receptor complexity by molecular exploitation","volume":"312","author":"Bridgham","year":"2006","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2215\/CJN.10741013","article-title":"Osmotic homeostasis","volume":"10","author":"Danziger","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000368264","article-title":"Mineralocorticoid-induced sodium appetite and renal salt retention: evidence for common signaling and effector mechanisms","volume":"128","author":"Fu","year":"2014","journal-title":"Nephron Physiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.18553\/jmcp.2007.13.s8-b.9","article-title":"The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition","volume":"13","author":"Atlas","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"B6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10157-016-1232-5","article-title":"Context-dependent mechanisms modulating aldosterone signaling in the kidney","volume":"20","author":"Shibata","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"E1032","DOI":"10.3390\/ijms18051032","article-title":"Aldosterone and mineralocorticoid receptors-physiology and pathophysiology","volume":"18","author":"Funder","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","article-title":"Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","article-title":"Localisation of 11 beta-hydroxysteroid dehydrogenase\u2013tissue specific protector of the mineralocorticoid receptor","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.steroids.2014.05.001","article-title":"Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome","volume":"91","author":"Marzolla","year":"2014","journal-title":"Steroids"},{"key":"B13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/01.CIR.0000048892.83521.58","article-title":"Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a set up for vascular disease","volume":"107","author":"Lakatta","year":"2003","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/01.CIR.0000048894.99865.02","article-title":"Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging","volume":"107","author":"Lakatta","year":"2003","journal-title":"Circulation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart disease and stroke statistics\u22122015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1161\/HYPERTENSIONAHA.117.10437","article-title":"Smooth muscle cell-mineralocorticoid receptor as a mediator of cardiovascular stiffness with aging","volume":"71","author":"Kim","year":"2018","journal-title":"Hypertension"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis","volume":"84","author":"Stocker","year":"2004","journal-title":"Physiol Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/01.HYP.0000123070.31763.55","article-title":"Modulation of the inflammatory response in cardiovascular disease","volume":"43","author":"Granger","year":"2004","journal-title":"Hypertension"},{"key":"B19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/01.HYP.0000078357.92682.EC","article-title":"Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling","volume":"42","author":"Pu","year":"2003","journal-title":"Hypertension"},{"key":"B20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.bbrc.2003.10.136","article-title":"Acidic polysaccharides isolated from Phellinus linteus induce phenotypic and functional maturation of murine dendritic cells","volume":"312","author":"Park","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.HYP.0000118519.66430.22","article-title":"Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone\/salt-induced hypertensive rats","volume":"43","author":"Nishiyama","year":"2004","journal-title":"Hypertension"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","article-title":"Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone","volume":"109","author":"Keidar","year":"2004","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/gerona\/60.12.1593","article-title":"Aldosterone and telomere length in white blood cells","volume":"60","author":"Benetos","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1161\/HYPERTENSIONAHA.109.148783","article-title":"Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signal-regulated kinase 1\/2 mitogen-activated protein kinase and epidermal growth factor receptor-dependent pathways","volume":"55","author":"Krug","year":"2010","journal-title":"Hypertension"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e88942","DOI":"10.1172\/jci.insight.88942","article-title":"Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging","volume":"1","author":"DuPont","year":"2016","journal-title":"JCI Insight"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/nm.2891","article-title":"Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors","volume":"18","author":"McCurley","year":"2012","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.117.028201","article-title":"Age-related autonomous aldosteronism","volume":"136","author":"Nanba","year":"2017","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1161\/HYPERTENSIONAHA.117.10391","article-title":"Aging and Adrenal Aldosterone Production","volume":"71","author":"Nanba","year":"2018","journal-title":"Hypertension"},{"key":"B29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/ki.1975.120","article-title":"Effect on aging on plasma renin and aldosterone in normal man","volume":"8","author":"Weidmann","year":"1975","journal-title":"Kidney Int"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/archinte.137.10.1414","article-title":"Age and the renin-aldosterone system","volume":"137","author":"Noth","year":"1977","journal-title":"Arch Intern Med"},{"key":"B31","first-page":"70","article-title":"[Renin-angiotensin-aldosterone system with regard to age]","volume":"21","author":"Zakharieva","year":"1982","journal-title":"Vutr Boles"},{"key":"B32","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2165\/00002512-199303030-00005","article-title":"Age-related changes in the renin-aldosterone system. Physiological effects and clinical implications","volume":"3","author":"Bauer","year":"1993","journal-title":"Drugs Aging"},{"key":"B33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3904\/kjim.2014.29.3.291","article-title":"The renin-angiotensin system and aging in the kidney","volume":"29","author":"Yoon","year":"2014","journal-title":"Kor J Intern Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.2215\/CJN.08611209","article-title":"Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations","volume":"5","author":"Turgut","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1210\/jcem-62-2-384","article-title":"Effect of age on the renin-angiotensin-aldosterone system in normal subjects: simultaneous measurement of active and inactive renin, renin substrate, and aldosterone in plasma","volume":"62","author":"Tsunoda","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","first-page":"411","article-title":"Age as a determinant of renal sodium conservation in normal man","volume":"87","author":"Epstein","year":"1976","journal-title":"J Lab Clin Med"},{"key":"B37","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1681\/ASN.V581573","article-title":"Down-regulation of the intrarenal renin-angiotensin system in the aging rat","volume":"5","author":"Jung","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"B38","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1681\/ASN.V651459","article-title":"Aldosterone responses to hyperkalemia in healthy elderly humans","volume":"6","author":"Mulkerrin","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2165\/00002512-199405050-00007","article-title":"Changes in the renin-angiotensin-aldosterone axis in later life","volume":"5","author":"Belmin","year":"1994","journal-title":"Drugs Aging"},{"key":"B40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0002-9343(86)90718-7","article-title":"Effects of aging on the renal glomerulus","volume":"80","author":"Anderson","year":"1986","journal-title":"Am J Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/ki.1987.122","article-title":"Relationship between vascular disease and age-associated changes in the human kidney","volume":"31","author":"Kasiske","year":"1987","journal-title":"Kidney Int"},{"key":"B42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/275144a0","article-title":"Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin","volume":"275","author":"Sealey","year":"1978","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s11255-008-9405-0","article-title":"Renal senescence in 2008: progress and challenges","volume":"40","author":"Zhou","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/ajh\/hps080","article-title":"Age-related changes in 11\u03b2-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects","volume":"26","author":"Campino","year":"2013","journal-title":"Am J Hypertens"},{"key":"B45","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cjca.2016.02.070","article-title":"Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications","volume":"32","author":"Harvey","year":"2016","journal-title":"Can J Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1146\/annurev.physiol.64.082101.143243","article-title":"Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors","volume":"64","author":"Rossier","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"T67","DOI":"10.1530\/JOE-17-0009","article-title":"30 years of the mineralocorticoid receptor: the role of the mineralocorticoid receptor in the vasculature","volume":"234","author":"DuPont","year":"2017","journal-title":"J Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1124\/pr.115.011106","article-title":"Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology","volume":"68","author":"Jaisser","year":"2016","journal-title":"Pharmacol Rev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0735-1097(00)01129-3","article-title":"Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats","volume":"37","author":"Lacolley","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1161\/01.ATV.17.6.1152","article-title":"Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats","volume":"17","author":"Benetos","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.115.05674","article-title":"Low-dose mineralocorticoid receptor blockade prevents western diet-induced arterial stiffening in female mice","volume":"66","author":"DeMarco","year":"2015","journal-title":"Hypertension"},{"key":"B52","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"B53","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/HYPERTENSIONAHA.107.103267","article-title":"Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients","volume":"51","author":"Savoia","year":"2008","journal-title":"Hypertension"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/j.1532-5415.2010.02905.x","article-title":"Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension","volume":"58","author":"Kithas","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"B55","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1161\/01.HYP.0000153793.84859.b8","article-title":"Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension","volume":"45","author":"O'Rourke","year":"2005","journal-title":"Hypertension"},{"key":"B56","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/2012.jama.10503","article-title":"Aortic stiffness, blood pressure progression, and incident hypertension","volume":"308","author":"Kaess","year":"2012","journal-title":"JAMA"},{"key":"B57","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.109.886655","article-title":"Arterial stiffness and cardiovascular events: the Framingham Heart Study","volume":"121","author":"Mitchell","year":"2010","journal-title":"Circulation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1161\/ATVBAHA.111.229070","article-title":"Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways","volume":"31","author":"Newfell","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1096\/fj.13-228312","article-title":"Long-term application of the aldosterone antagonist spironolactone prevents stiff endothelial cell syndrome","volume":"27","author":"Dr\u00fcppel","year":"2013","journal-title":"FASEB J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1161\/CIRCRESAHA.115.308269","article-title":"Endothelial mineralocorticoid receptor mediates diet-induced aortic stiffness in females","volume":"118","author":"Jia","year":"2016","journal-title":"Circ Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fcvm.2018.00081","article-title":"No significant role for smooth muscle cell mineralocorticoid receptors in atherosclerosis in the apolipoprotein-E knockout mouse model","volume":"5","author":"Moss","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1161\/ATVBAHA.119.312954","article-title":"Endothelial mineralocorticoid receptors contribute to vascular inflammation in atherosclerosis in a sex-specific manner","volume":"39","author":"Moss","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice","volume":"120","author":"Usher","year":"2010","journal-title":"J Clin Invest"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1161\/CIRCRESAHA.116.310480","article-title":"T-cell mineralocorticoid receptor controls blood pressure by regulating interferon-gamma","volume":"120","author":"Sun","year":"2017","journal-title":"Circ Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1074\/jbc.M116.739243","article-title":"Mineralocorticoid receptor deficiency in macrophages inhibits atherosclerosis by affecting foam cell formation and efferocytosis","volume":"292","author":"Shen","year":"2017","journal-title":"J Biol Chem"},{"key":"B66","first-page":"158","article-title":"Aging and cardiac fibrosis","volume":"2","author":"Biernacka","year":"2011","journal-title":"Aging Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1161\/HYPERTENSIONAHA.112.198986","article-title":"Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo","volume":"61","author":"Messaoudi","year":"2013","journal-title":"Hypertension"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1210\/en.2016-1040","article-title":"Cardiac tissue injury and remodeling is dependent upon MR regulation of activation pathways in cardiac tissue macrophages","volume":"157","author":"Shen","year":"2016","journal-title":"Endocrinology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/MNH.0b013e3282f56854","article-title":"Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation","volume":"17","author":"Young","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1161\/CIRCULATIONAHA.111.067918","article-title":"Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling","volume":"124","author":"Leopold","year":"2011","journal-title":"Circulation"},{"key":"B71","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1161\/01.RES.71.3.503","article-title":"Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor","volume":"71","author":"Lomb\u00e8s","year":"1992","journal-title":"Circ Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/CS20130050","article-title":"Mineralocorticoid receptors and the heart, multiple cell types and multiple mechanisms: a focus on the cardiomyocyte","volume":"125","author":"Bienvenu","year":"2013","journal-title":"Clin Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"H2035","DOI":"10.1152\/ajpheart.00552.2010","article-title":"Coronary endothelial dysfunction after cardiomyocyte-specific mineralocorticoid receptor overexpression","volume":"300","author":"Favre","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1042\/CS20080247","article-title":"Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart","volume":"116","author":"Wilson","year":"2009","journal-title":"Clin Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1210\/en.2011-2098","article-title":"Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis","volume":"153","author":"Bienvenu","year":"2012","journal-title":"Endocrinology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4049\/jimmunol.0802886","article-title":"Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity","volume":"184","author":"Herrada","year":"2010","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.117.09070","article-title":"Mineralocorticoid receptor deficiency in T cells attenuates pressure overload-induced cardiac hypertrophy and dysfunction through modulating T-cell activation","volume":"70","author":"Li","year":"2017","journal-title":"Hypertension"},{"key":"B79","doi-asserted-by":"publisher","first-page":"H175","DOI":"10.1152\/ajpheart.00660.2006","article-title":"Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR","volume":"292","author":"Susic","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/1440-1681.12156","article-title":"Mineralocorticoid receptor and cardiac arrhythmia","volume":"40","author":"Gravez","year":"2013","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1161\/CIRCULATIONAHA.108.805804","article-title":"Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins","volume":"119","author":"G\u00f3mez","year":"2009","journal-title":"Circulation"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1161\/CIRCULATIONAHA.104.503706","article-title":"Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias","volume":"111","author":"Ouvrard-Pascaud","year":"2005","journal-title":"Circulation"},{"key":"B83","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"B84","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.jacc.2009.09.045","article-title":"Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation","volume":"55","author":"Tsai","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"III27","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"B86","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11906-003-0055-4","article-title":"Endothelial nitric oxide synthase and endothelial dysfunction","volume":"5","author":"Huang","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"B87","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/HCO.0b013e3281ca710d","article-title":"Endothelial function and hypertension","volume":"22","author":"Landmesser","year":"2007","journal-title":"Curr Opin Cardiol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.amjcard.2004.03.015","article-title":"Effect of spironolactone on endothelial function in patients with congestive heart failure on conventional medical therapy","volume":"93","author":"Abiose","year":"2004","journal-title":"Am J Cardiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","article-title":"Mineralocorticoid receptor antagonism in experimental atherosclerosis","volume":"105","author":"Rajagopalan","year":"2002","journal-title":"Circulation"},{"key":"B91","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cardfail.2006.01.002","article-title":"Aldosterone antagonism improves endothelial-dependent vasorelaxation in heart failure via upregulation of endothelial nitric oxide synthase production","volume":"12","author":"Thai","year":"2006","journal-title":"J Card Fail"},{"key":"B92","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/HYPERTENSIONAHA.115.06530","article-title":"Deoxycorticosterone acetate\/salt-induced cardiac but not renal injury is mediated by endothelial mineralocorticoid receptors independently from blood pressure","volume":"67","author":"Lother","year":"2016","journal-title":"Hypertension"},{"key":"B93","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijcard.2017.01.013","article-title":"Essential role of ICAM-1 in aldosterone-induced atherosclerosis","volume":"232","author":"Marzolla","year":"2017","journal-title":"Int J Cardiol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0895-7061(01)02291-9","article-title":"Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1","volume":"15","author":"Park","year":"2002","journal-title":"Am J Hypertens"},{"key":"B95","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.lfs.2017.05.002","article-title":"Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: the aldosterone-mineralocorticoid receptor-Nox1 axis","volume":"179","author":"Harvey","year":"2017","journal-title":"Life Sci"},{"key":"B96","doi-asserted-by":"publisher","first-page":"H1015","DOI":"10.1152\/ajpheart.01047.2002","article-title":"NAD(P)H oxidase-generated superoxide anion accounts for reduced control of myocardial O2 consumption by NO in old Fischer 344 rats","volume":"285","author":"Adler","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1474-9726.2011.00679.x","article-title":"Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging","volume":"10","author":"Sindler","year":"2011","journal-title":"Aging Cell"},{"key":"B98","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/HYPERTENSIONAHA.107.093450","article-title":"Mineralocorticoid receptor blockade improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction","volume":"50","author":"Sart\u00f3rio","year":"2007","journal-title":"Hypertension"},{"key":"B99","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.115.07074","article-title":"Aldosterone-induced vascular remodeling and endothelial dysfunction require functional angiotensin type 1a receptors","volume":"67","author":"Briet","year":"2016","journal-title":"Hypertension"},{"key":"B100","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1177\/1535370214522586","article-title":"Temporary mineralocorticoid receptor antagonism during the development of hypertension improves cerebral artery dilation","volume":"239","author":"McClain","year":"2014","journal-title":"Exp Biol Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1093\/eurheartj\/eht095","article-title":"Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity","volume":"34","author":"Sch\u00e4fer","year":"2013","journal-title":"Eur Heart J"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e007675","DOI":"10.1161\/JAHA.117.007675","article-title":"Sex-specific mechanisms of resistance vessel endothelial dysfunction induced by cardiometabolic risk factors","volume":"7","author":"Davel","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B103","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/HYPERTENSIONAHA.115.06172","article-title":"Endothelial mineralocorticoid receptors differentially contribute to coronary and mesenteric vascular function without modulating blood pressure","volume":"66","author":"Mueller","year":"2015","journal-title":"Hypertension"},{"key":"B104","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.amjhyper.2004.08.026","article-title":"Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension","volume":"18","author":"Mahmud","year":"2005","journal-title":"Am J Hypertens"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","article-title":"Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension","volume":"41","author":"White","year":"2003","journal-title":"Hypertension"},{"key":"B106","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.exger.2013.05.058","article-title":"Role of mineralocorticoid receptors in arterial stiffness in human aging","volume":"48","author":"Hwang","year":"2013","journal-title":"Exp Gerontol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.exger.2015.11.017","article-title":"Acute effect of mineralocorticoid receptor antagonism on vascular function in healthy older adults","volume":"73","author":"Hwang","year":"2016","journal-title":"Exp Gerontol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/FJC.0b013e3181bfb00d","article-title":"Nitric oxide-mediated dilation of arterioles to intraluminal administration of aldosterone","volume":"54","author":"Heylen","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/01.CIR.0000048893.62841.F7","article-title":"Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease","volume":"107","author":"Lakatta","year":"2003","journal-title":"Circulation"},{"key":"B110","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.04-2622fje","article-title":"Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging","volume":"19","author":"Judge","year":"2005","journal-title":"FASEB J"},{"key":"B111","doi-asserted-by":"publisher","first-page":"H37","DOI":"10.1152\/ajpheart.01346.2006","article-title":"Increased mitochondrial H2O2 production promotes endothelial NF-kappaB activation in aged rat arteries","volume":"293","author":"Ungvari","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s00018-009-0015-5","article-title":"DNA hypomethylation in the origin and pathogenesis of human diseases","volume":"66","author":"Pogribny","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1161\/01.ATV.19.9.2171","article-title":"Local hypomethylation in atherosclerosis found in rabbit ec-sod gene","volume":"19","author":"Laukkanen","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1161\/ATVBAHA.111.224881","article-title":"Mechanisms of ER stress-induced apoptosis in atherosclerosis","volume":"31","author":"Scull","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"235","DOI":"10.14797\/mdcj-11-4-235","article-title":"Mineralocorticoid receptor antagonists for treatment of hypertension and heart failure","volume":"11","author":"Sica","year":"2015","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"B116","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"B117","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1161\/CIR.0b013e31828124ad","article-title":"Heart disease and stroke statistics\u22122013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"B118","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"B119","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1011119003788","article-title":"The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study","volume":"15","author":"Pitt","year":"2001","journal-title":"Cardiovasc Drugs Ther"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist. (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"B123","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/ageing\/afw138","article-title":"Mineralocorticoid receptor antagonists in elderly patients with heart failure: a systematic review and meta-analysis","volume":"46","author":"Japp","year":"2017","journal-title":"Age Ageing"},{"key":"B124","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jchf.2019.01.003","article-title":"Sex differences in outcomes and responses to spironolactone in heart failure with preserved ejection fraction: a secondary analysis of TOPCAT trial","volume":"7","author":"Merrill","year":"2019","journal-title":"JACC Heart Fail"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.amjcard.2010.07.037","article-title":"Effect of combined spironolactone-\u03b2-blocker \u00b1 enalapril treatment on occurrence of symptomatic atrial fibrillation episodes in patients with a history of paroxysmal atrial fibrillation","volume":"106","author":"Dabrowski","year":"2010","journal-title":"Am J Cardiol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e007987","DOI":"10.1161\/JAHA.117.007987","article-title":"Mineralocorticoid receptor antagonism in patients with atrial fibrillation: findings from the ORBIT-AF. (outcomes registry for better informed treatment of atrial fibrillation) Registry","volume":"7","author":"Fudim","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B127","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"B128","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s40266-015-0306-5","article-title":"Antihypertensive medications, loop diuretics, and risk of hip fracture in the elderly: a population-based cohort study of 81,617 italian patients newly treated between 2005 and 2009","volume":"32","author":"Corrao","year":"2015","journal-title":"Drugs Aging"},{"key":"B129","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"key":"B130","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s10741-011-9286-7","article-title":"The role of mineralocorticoid receptor antagonists (MRAs) in very old patients with heart failure","volume":"17","author":"Pitt","year":"2012","journal-title":"Heart Fail Rev"},{"key":"B131","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11906-016-0649-2","article-title":"Finerenone: a new mineralocorticoid receptor antagonist without hyperkalemia: an opportunity in patients with CKD?","volume":"18","author":"Haller","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1517\/13543784.2015.1059819","article-title":"Finerenone : third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease","volume":"24","author":"Liu","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"B133","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/164_2016_76","article-title":"Steroidal and novel non-steroidal mineralocorticoid receptor antagonists in heart failure and cardiorenal diseases: comparison at bench and bedside","volume":"243","author":"Kolkhof","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/jama.2015.10081","article-title":"Effect of Finerenone on Albuminuria in patients with diabetic nephropathy: a randomized clinical trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"B135","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1093\/eurheartj\/ehw132","article-title":"A randomized controlled study of Finerenone vs. Eplerenone in patients with worsening chronic heart failure and diabetes mellitus and\/or chronic kidney disease","volume":"37","author":"Filippatos","year":"2016","journal-title":"Eur Heart J"},{"key":"B136","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1161\/HYPERTENSIONAHA.117.10360","article-title":"Selective mineralocorticoid receptor cofactor modulation as molecular basis for Finerenone's antifibrotic activity","volume":"71","author":"Grune","year":"2018","journal-title":"Hypertension"},{"key":"B137","doi-asserted-by":"publisher","first-page":"E96","DOI":"10.3390\/biom8030096","article-title":"Mineralocorticoid receptor and aldosterone-related biomarkers of end-organ damage in cardiometabolic disease","volume":"8","author":"Gorini","year":"2018","journal-title":"Biomolecules"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00584\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T03:02:54Z","timestamp":1664161374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00584\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,23]]},"references-count":137,"alternative-id":["10.3389\/fendo.2019.00584"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00584","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,23]]},"article-number":"584"}}